Minghui Pharmaceutical
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (19)
MHB018A Treatment in Patients With Active Thyroid Eye Disease
Started: 7/22/2025
Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease
Started: 1/9/2026
MHB018A Treatment in Patients With Chronic Thyroid Eye Disease
Started: 3/17/2026
A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis
Started: 6/10/2023
Treatment of Chronic Thyroid Eye Disease With MHB018A
Started: 12/1/2026
Treatment of Active Thyroid Eye Disease With MHB018A in a Randomized, Placebo-Controlled Study
Started: 12/1/2026
Open-Label Extension Study of MHB018A in Patients With Thyroid Eye Disease
Started: 7/1/2027
A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors
Started: 9/30/2025
Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo
Started: 3/26/2024
A Study of MHB009C in Patients With Advanced Solid Tumors
Started: 3/17/2026
A Study of MHB048C in Patients With Advanced Solid Tumors
Started: 1/16/2026
A Study of MHB042C in Patients With Advanced Solid Tumors
Started: 11/27/2025
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
Started: 9/18/2025
A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
Started: 5/9/2025
A Study of MHB046C Injection in Patients With Advanced Solid Tumors
Started: 7/17/2025
A Study of MHB118C Injection in Patients With Advanced Solid Tumors
Started: 3/31/2025
A Study of MHB039A for Advanced Solid Tumor
Started: 4/16/2024
A Study of MHB036C for Advanced Solid Tumor
Started: 5/26/2023
MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis
Started: 1/6/2022